Companies / Rarity Bioscience
Rarity Bioscience
Company
Rarity Bioscience develops ultra-sensitive mutations assays designed to run on available instruments and standard flow-cytometers.
Rarity Bioscience has 2 investors on file, among them Navigare Ventures and Novalis Biotech Incubation. Its site was last checked 13 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from Navigare Ventures
31 companies on its checked portfolioIts portfolio leans to AI & Machine Learning (29%), Industrial & Manufacturing (24%), Healthcare & Biotech (22%).
See Navigare Ventures' full profile · Who invests alongside it
More from Novalis Biotech Incubation
16 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (94%), Consumer (6%).
See Novalis Biotech Incubation's full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Rarity Bioscience and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Navigare Ventures adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/raritybioscience.com/investors
# also
GET /v1/companies/raritybioscience.com
GET /v1/companies/raritybioscience.com/news